ArticleChinese medicine2025
Colla Corii Asini regulate collagen regeneration in UV exposure-induced skin photoaging in mice.
Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundUltraviolet (UV) radiation is the primary external factor driving skin aging, mainly due to imbalanced collagen synthesis and degradation. Identifying new drugs targeting collagen regeneration may effectively delay skin aging. Colla Corii Asini (CCA), derived from donkey skin, contains abundant proteins and peptides, suggesting potential benefits against photoaging through collagen homeostasis regulation. However, its mechanisms and active components remain unclear.
objectiveThis study aimed to evaluate whether CCA mitigates photoaging by regulating collagen synthesis and degradation, identifying its active components and molecular targets to support future pharmacological studies.
methodsA photoaging mouse model was established, and the therapeutic effects of CCA were assessed through in vivo optical imaging and ex vivo analyses. Human dermal fibroblasts were employed to explore mechanisms of collagen regulation by CCA. PPI analysis and AlphaFold3 were used to predict and validate key active peptides and molecular targets.
resultsCCA significantly improved the structure and appearance of photoaged skin, reduced oxidative stress and inflammation, and enhanced collagen content and density. Mass spectrometry identified 98 peptides closely linked to protein synthesis. Mechanistically, CCA increased collagen synthesis and reduced aging markers by activating the TGFβ-SMAD signaling pathway, balancing MMPs and TIMPs. Importantly, this effect is primarily associated with the core CCA peptide YYTSASGDEMVSLK binding to and upregulating TGFBR1 and TGFBR2 expression, activating the TGFβ-SMAD pathway, and promoting collagen regeneration.
conclusionCCA, particularly peptide YYTSASGDEMVSLK, has potential to slow skin photoaging, highlighting a promising therapeutic strategy for skin aging management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.